Healthcare

We cover the complete value chain in the pharmaceuticals and healthcare sector

We offer customized approaches that take account of our clients' specific business model. We do not stop at concepts – we help implement them successfully.

The Chinese government has formulated an ambitious healthcare reform plan which will engage a large amount of resources to improve the healthcare infrastructures in China. Within the next 10 years, this infrastructure will work to raise healthcare insurance coverage, as well as reallocate interests among hospitals, drug manufacturers, drug distributors and patients. While this remarkable reform will provide tremendous opportunities for various players in the value chain, it will at the same time pose significant challenges.

Roland Berger Greater China Healthcare Competence Center closely keeps up with the development of the Chinese healthcare system and provides high quality and relevant consulting services to various types of clients, including pharmaceutical companies, medical device manufacturers, hospital management organizations and private equity investors.

Our consulting services include: China market entry strategy, overseas merger and acquisition strategy, regional expansion strategy, sales and marketing effectiveness improvement strategy, sales and commercial distribution channel setup, new product development strategy, hospital management organization performance improvement strategy, hospital chain expansion strategy, medical device market expansion and new product development strategy.

> Strategic positioning and long-term growth plan
> China market entry for multinational corporations and Chinese corporations going global strategy
> Geographic expansion strategy
> New product development strategy
> R&D strategy
> Operation performance assessment and implementation of improvement plan
> Hospital performance improvement and hospital chain expansion strategy

> Led a 5-year geographic expansion and resource allocation strategy, and improved the effectiveness of marketing and sales for a world leading pharmaceutical company's OTC division
> Improved sales and marketing operation and resource allocation strategy for a world leading pharmaceutical company's nutrition products division
> Conducted due diligence for a globally renowned private equity firm on its investment in a traditional Chinese medicine manufacturer
> Developed new product and distribution channel strategy for a globally leading pharmaceutical company
> Created an effective merger and acquisition strategy for a world leading pharmaceutical company
> Improved the performance and hospital chain expansion strategy for a leading Chinese hospital management corporation

Contact

Matthew Chang
Partner